// App-Quantinova.ai

436 : Clinical Characteristics and Outcome of ANCA-Associated Vasculitides Induced by Anti-Thyroid Drugs: A Multicenter Retrospective Cohort Study

Researchers

Presenter

  • Julien Culerrier

Principal Investigators

  • Omer Karadag

  • Sule Yasar Bilge

  • Tuba DEMIRCI YILDIRIM

  • Tahir Saygin Öğüt

  • Veli Yazisiz

  • Cemal Bes

  • Ayse Cefle

  • Oznur Sadioglu Cagdas

  • Ayten Yazici

  • Andreas Kronbichler

  • David Jayne

  • Alexis Regent

  • Vitor Teixeira

  • Sylvain Marchand-Adam

  • PIerre Duffau

  • Saskia Oro

  • Baptiste Andre

  • Luminita Luca

  • Sarah Lechtman

  • Achille Aouba

  • Celine Lebas

  • Amélie Servettaz

  • Amandine Dernoncourt

  • Marc Ruivard

  • Anne-Marie Milesi

  • Vincent Poindron

  • Patrick Jego

  • Roberto Padoan

  • Paolo Delvino

  • Frédéric Vandergheynst

  • Christian Pagnoux

  • Elaine Yacyshyn

  • Peter Lamprecht

  • Oliver Flossmann

  • Xavier Puéchal

  • Benjamin Terrier

Medical Centers

  • Université Paris Cité, Paris, France, Paris, France

  • AP-HP.Centre Universit Paris Cit Hôpital Cochin, Montmorency, France

  • Hacettepe University, Ankara, Turkey

  • Eskişehir Osmangazi Üniversity, Eskisehir, Turkey

  • Dokuz Eylul University, Izmir, Turkey

  • Akdeniz University, Antalya, Turkey

  • Bahçeşehi University, Istanbul, Turkey

  • Kocaeli University, Faculty of Medicine, Division of Rheumatology, Kocaeli, Kocaeli, Turkey

  • Kocaeli University, Kocaeli, Turkey

  • University of Cambridge, Cambridge, United Kingdom

  • National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France

  • Hospital de Faro, CHUA, Lisbon, Portugal

  • Toulouse University Hospital, Toulouse, France

  • CHU Bordeaux, Bordeaux, France

  • Hopital de la Timone, CHU de Marseille AP-HM, Marseille, France

  • CHU Poitiers, Poitiers, France

  • CHU de Nice, Nice, France

  • Department of Internal Medicine, UR4650 PSIR, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France

  • CHRU Lille, Lille, France

  • CHU Reims, Reims, France

  • CHU Amiens-Picardie, Amiens, France

  • Clermont-Ferrand University Hospital, Clermont-Ferrand, France

  • Centre hospitalier de Nice, Nice, France

  • Immunologie clinique et médecine interne, Hôpitaux universitaires de Strasbourg, Strasbourg, France

  • CHU Rennes, Paris, France

  • University of Pavia, Pavia, Italy

  • Università di Pavia, Vercelli, Italy

  • Professeur de Médecine Interne et Sémiologie médicale, Directeur de la Clinique de Médecine Interne Générale, Université Libre de Bruxelles, Bruxelles, France

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

  • University of Alberta, Edmonton, AB, Canada

  • Department of Rheumatology University of Lübeck Ratzeburger Allee, Lübeck, Germany

  • Royal Berkshire Hospital NHS Trust, Reading, United Kingdom

Locations

  • France

  • Turkey

  • United Kingdom

  • Portugal

  • Italy

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

  • Microscopic polyangiitis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved